MSA
MRNA icon

Marino Stram & Associates’s Moderna MRNA Stock Holding History

Marino Stram & Associates’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,249
Closed -$317K – 147
2021
Q4 		$317K Buy
1,249
+38
+3% +$11.1K 0.1% 124
2021
Q3 		$466K Buy
+1,211
New +$447K 0.16% 94

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marino Stram & Associates's MRNA Position: Q1 2022 in Review

Marino Stram & Associates sold out of Moderna (MRNA) in Q1 2022, closing a stake of 1,249 shares — an estimated $317K sold.

Marino Stram & Associates first reported a position in MRNA in Q3 2021 and held it in 2 quarters. The position peaked at $466K in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Marino Stram & Associates reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Marino Stram & Associates sold 1,249 Moderna shares in Q1 2022, an estimated $317K.
  • Marino Stram & Associates first reported a position in Moderna in Q3 2021 and held it in 2 quarters.
  • Marino Stram & Associates's Moderna position peaked at $466K in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Marino Stram & Associates's 13F filing for Q1 2022, filed 25 Apr 2022.